New drug injection aims to stop painful, Life-Threatening pancreas attacks

NCT ID NCT06880770

Recruiting now Disease control Sponsor: Arrowhead Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an investigational drug called plozasiran can prevent episodes of acute pancreatitis in adults with severely high blood triglycerides who have had pancreatitis before. About 288 participants will receive either plozasiran or a placebo injection every three months, along with a low-fat diet and standard medications. The main goal is to see if the drug reduces the risk of future painful and dangerous pancreas attacks.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Research Site 1
RECRUITING

Mesquite, Texas, 75149, United States
Clinical Research Site 2
RECRUITING

San Antonio, Texas, 78233, United States
Clinical Research Site 3
RECRUITING

Greensboro, North Carolina, 27401, United States
Clinical Research Site 4
RECRUITING

Santa Clarita, California, 91321, United States
Clinical Research Site 5
RECRUITING

North Platte, Nebraska, 69101, United States
Clinical Research Site 6
RECRUITING

Springfield, Illinois, 62702, United States
Clinical Research Site 7
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
Research Center
RECRUITING

Plovdiv, 4002, Bulgaria
Research Center
RECRUITING

Beijing, Beijing Municipality, 100730, China
Research Center
RECRUITING

Baotou, Inner Mongolia, 014010, China
Research Center
RECRUITING

Nanchang, Jiangxi, 330006, China
Research Center
RECRUITING

Shanghai, Shanghai Municipality, 201620, China
Research Center
RECRUITING

Hangzhou, Zhejiang, 310000, China
Research Center
RECRUITING

Amman, 11821, Jordan
Research Center
RECRUITING

Irbid, 21166, Jordan
Research Center
RECRUITING

Irbid, 22110, Jordan
Research Center
RECRUITING

Belgrade, 11000, Serbia
Research Center
RECRUITING

Zaječar, 19000, Serbia
Research Center
RECRUITING

Gothenburg, 41345, Sweden
Research Center
RECRUITING

Stockholm, 14186, Sweden
Research Site
RECRUITING

Los Angeles, California, 90027, United States
Research Site
RECRUITING

Indianapolis, Indiana, 46202, United States
Research Site
RECRUITING

Kansas City, Kansas, 66160, United States
Research Site
RECRUITING

St Louis, Missouri, 63110, United States
Research Site
RECRUITING

Wilmington, North Carolina, 28412, United States
Research Site
RECRUITING

Graz, 8036, Austria
Research Site
RECRUITING

Fortaleza, Ceará, 60430-370, Brazil
Research Site
RECRUITING

Belo Horizonte, Minas Gerais, 30150-274, Brazil
Research Site
RECRUITING

Belo Horizonte, Minas Gerais, 30150-320, Brazil
Research Site
RECRUITING

Belo Horizonte, Minas Gerais, 30220-140, Brazil
Research Site
RECRUITING

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
Research Site
RECRUITING

Pôrto Alegre, Rio Grande do Sul, 90050-170, Brazil
Research Site
RECRUITING

Burgas, 8000, Bulgaria
Research Site
RECRUITING

Pleven, 5800, Bulgaria
Research Site
RECRUITING

Plovdiv, 4003, Bulgaria
Research Site
RECRUITING

Rousse, 7013, Bulgaria
Research Site
RECRUITING

Sofia, 1404, Bulgaria
Research Site
RECRUITING

Sofia, 1431, Bulgaria
Research Site
RECRUITING

Stara Zagora, 6000, Bulgaria
Research Site
RECRUITING

Guiyang, Guizhou, 550000, China
Research Site
RECRUITING

Harbin, Heilongjiang, 150040, China
Research Site
RECRUITING

Chifeng, Inner Mongolia, 024099, China
Research Site
RECRUITING

Hangzhou, Zhejiang, 310003, China
Research Site
RECRUITING

Beijing, 100053, China
Research Site
RECRUITING

Nanjing, 210002, China
Research Site
RECRUITING

Budapest, 1083, Hungary
Research Site
RECRUITING

Budapest, 1132, Hungary
Research Site
RECRUITING

Szeged, 6725, Hungary
Research Site
RECRUITING

Amman, 11190, Jordan
Research Site
RECRUITING

Amman, 11942, Jordan
Research Site
RECRUITING

Muscat, 123, Oman
Research Site
RECRUITING

Belgrade, 11000, Serbia
Research Site
RECRUITING

Pančevo, 26000, Serbia
Research Site
RECRUITING

Jeonju, Jeollabuk-do, 54907, South Korea
Research Site
RECRUITING

Busan, 49201, South Korea
Research Site
RECRUITING

Sejong, 30099, South Korea
Research Site
RECRUITING

Seoul, 05505, South Korea
Research Site
RECRUITING

Seoul, 06351, South Korea
Research Site
RECRUITING

Abu Dhabi, 133500, United Arab Emirates
Research Site
RECRUITING

Abu Dhabi, 51900, United Arab Emirates
Research Site
RECRUITING

Al Ain City, 15258, United Arab Emirates

Conditions

Explore the condition pages connected to this study.

SEVERE HYPERTRIGLYCERIDEMIA